Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Lewin-Koh

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 21, 2014
Development of a safety biomarker signature to detect hepatic sinusoidal dilation associated with an anti-DLL4 biotherapeuticJacqueline M Tarrant, Sock-Cheng Lewin-Koh, Nicholas Lewin-Koh
Current Protocols in Protein Science|April 3, 2013
Protein microarrays for identification of novel extracellular protein-protein interactionsIrene Tom, Nicholas Lewin-Koh, Sree R Ramani, et al.
Biotechnology and Bioengineering|November 29, 2013
Semisynthetic model calibration for monitoring glucose in mammalian cell culture with in situ near infrared spectroscopyMichael Milligan, Nicholas Lewin-Koh, Daniel Coleman, et al.
BMC Cancer|October 29, 2010
Statistical techniques to construct assays for identifying likely responders to a treatment under evaluation from cell line genomic dataErich P Huang, Jane Fridlyand, Nicholas Lewin-Koh, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
PK-PD modeling of combination efficacy effect from administration of the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 in A2058 xenograftsEdna F Choo, Chee M Ng, Leanne Berry, et al.
Hepatology (Baltimore, Md.)|August 22, 2022
Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trialChin Wong, Ajit Dash, Jill Fredrickson, et al.
Analytical Biochemistry|October 11, 2011
A secreted protein microarray platform for extracellular protein interaction discoverySree R Ramani, Irene Tom, Nicholas Lewin-Koh, et al.
Biotechniques|March 15, 2006
Quantitative determination of peptides using matrix-assisted laser desorption/ionization time-of-flight mass spectrometryJesus A Gutierrez, Jill A Dorocke, Michael D Knierman, et al.
Plos One|October 30, 2019
Sustained activity of novel THIOMAB antibody-antibiotic conjugate against Staphylococcus aureus in a mouse model: Longitudinal pharmacodynamic assessment by bioluminescence imagingChenguang Zhou, Hao Cai, Amos Baruch, et al.
Plos One|May 3, 2013
EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALSClaire E Le Pichon, Sara L Dominguez, Hilda Solanoy, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 21, 2014
Development of a safety biomarker signature to detect hepatic sinusoidal dilation associated with an anti-DLL4 biotherapeuticJacqueline M Tarrant, Sock-Cheng Lewin-Koh, Nicholas Lewin-Koh
Current Protocols in Protein Science|April 3, 2013
Protein microarrays for identification of novel extracellular protein-protein interactionsIrene Tom, Nicholas Lewin-Koh, Sree R Ramani, et al.
Biotechnology and Bioengineering|November 29, 2013
Semisynthetic model calibration for monitoring glucose in mammalian cell culture with in situ near infrared spectroscopyMichael Milligan, Nicholas Lewin-Koh, Daniel Coleman, et al.
BMC Cancer|October 29, 2010
Statistical techniques to construct assays for identifying likely responders to a treatment under evaluation from cell line genomic dataErich P Huang, Jane Fridlyand, Nicholas Lewin-Koh, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
PK-PD modeling of combination efficacy effect from administration of the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 in A2058 xenograftsEdna F Choo, Chee M Ng, Leanne Berry, et al.
Hepatology (Baltimore, Md.)|August 22, 2022
Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trialChin Wong, Ajit Dash, Jill Fredrickson, et al.
Analytical Biochemistry|October 11, 2011
A secreted protein microarray platform for extracellular protein interaction discoverySree R Ramani, Irene Tom, Nicholas Lewin-Koh, et al.
Biotechniques|March 15, 2006
Quantitative determination of peptides using matrix-assisted laser desorption/ionization time-of-flight mass spectrometryJesus A Gutierrez, Jill A Dorocke, Michael D Knierman, et al.
Plos One|October 30, 2019
Sustained activity of novel THIOMAB antibody-antibiotic conjugate against Staphylococcus aureus in a mouse model: Longitudinal pharmacodynamic assessment by bioluminescence imagingChenguang Zhou, Hao Cai, Amos Baruch, et al.
Plos One|May 3, 2013
EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALSClaire E Le Pichon, Sara L Dominguez, Hilda Solanoy, et al.
Pageof 3